Dolby Laboratories (NYSE:DLB) insider Kevin J. Yeaman sold 45,000 shares of the firm’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $56.46, for a total value of $2,540,700.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Kevin J. Yeaman also recently made the following trade(s):

  • On Wednesday, August 2nd, Kevin J. Yeaman sold 10,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.79, for a total value of $517,900.00.

Shares of Dolby Laboratories (NYSE:DLB) traded up 0.17% on Friday, reaching $58.29. The company had a trading volume of 611,570 shares. Dolby Laboratories has a 52 week low of $44.99 and a 52 week high of $59.79. The firm has a market capitalization of $5.98 billion, a P/E ratio of 29.82 and a beta of 0.81. The company’s 50-day moving average price is $51.12 and its 200 day moving average price is $51.12.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Tuesday, July 25th. The electronics maker reported $0.75 earnings per share for the quarter, topping analysts’ consensus estimates of $0.65 by $0.10. Dolby Laboratories had a return on equity of 10.25% and a net margin of 19.02%. The company had revenue of $305.67 million during the quarter, compared to analysts’ expectations of $296.88 million. During the same period last year, the firm earned $0.62 EPS. The firm’s revenue for the quarter was up 10.1% on a year-over-year basis. On average, analysts expect that Dolby Laboratories will post $1.99 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of US & international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/16/dolby-laboratories-dlb-insider-kevin-j-yeaman-sells-45000-shares-of-stock.html.

A number of institutional investors have recently bought and sold shares of DLB. Watermark Asset Management Inc. acquired a new stake in Dolby Laboratories during the 1st quarter worth approximately $114,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Dolby Laboratories by 9.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,331 shares of the electronics maker’s stock worth $114,000 after acquiring an additional 209 shares during the period. US Bancorp DE lifted its position in Dolby Laboratories by 2.6% during the 2nd quarter. US Bancorp DE now owns 3,029 shares of the electronics maker’s stock worth $149,000 after acquiring an additional 78 shares during the period. The Manufacturers Life Insurance Company lifted its position in Dolby Laboratories by 25.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,564 shares of the electronics maker’s stock worth $174,000 after acquiring an additional 725 shares during the period. Finally, Teacher Retirement System of Texas lifted its position in Dolby Laboratories by 4.6% during the 2nd quarter. Teacher Retirement System of Texas now owns 4,637 shares of the electronics maker’s stock worth $227,000 after acquiring an additional 205 shares during the period. 51.88% of the stock is owned by institutional investors.

Several equities research analysts have weighed in on DLB shares. B. Riley reissued a “buy” rating and issued a $61.50 price target on shares of Dolby Laboratories in a report on Friday, July 28th. Dougherty & Co reissued a “buy” rating and issued a $63.00 price target on shares of Dolby Laboratories in a report on Wednesday. Piper Jaffray Companies reissued a “hold” rating and issued a $52.00 price target (up previously from $49.00) on shares of Dolby Laboratories in a report on Wednesday. BidaskClub upgraded Dolby Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, July 8th. Finally, Zacks Investment Research upgraded Dolby Laboratories from a “sell” rating to a “hold” rating in a research note on Tuesday, July 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. Dolby Laboratories presently has an average rating of “Hold” and a consensus target price of $57.30.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Stock Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related stocks with our FREE daily email newsletter.